Generation of glucocorticoid-resistant SARS-CoV-2 T cells for adoptive cell therapy

Adoptive cell therapy with virus-specific T cells has been used successfully to treat life-threatening viral infections, supporting application of this approach to coronavirus disease 2019 (COVID-19). We expand severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) T cells from the peripheral...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cell Rep
Main Authors: Basar, Rafet, Uprety, Nadima, Ensley, Emily, Daher, May, Klein, Kimberly, Martinez, Fernando, Aung, Fleur, Shanley, Mayra, Hu, Bingqian, Gokdemir, Elif, Nunez Cortes, Ana Karen, Mendt, Mayela, Reyes Silva, Francia, Acharya, Sunil, Laskowski, Tamara, Muniz-Feliciano, Luis, Banerjee, Pinaki P., Li, Ye, Li, Sufang, Melo Garcia, Luciana, Lin, Paul, Shaim, Hila, Yates, Sean G., Marin, David, Kaur, Indreshpal, Rao, Sheetal, Mak, Duncan, Lin, Angelique, Miao, Qi, Dou, Jinzhuang, Chen, Ken, Champlin, Richard E., Shpall, Elizabeth J., Rezvani, Katayoun
Formato: Artigo
Idioma:Inglês
Publicado em: The Authors. 2021
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8260499/
https://ncbi.nlm.nih.gov/pubmed/34270918
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.celrep.2021.109432
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados